HDAC-IN-32
HDAC-IN-32 is a potent HDAC inhibitor with IC50s of 5.2, 11, and 28 nM for HDAC1, HDAC2 and HDAC6, respectively. HDAC-IN-32 possesses potent antiproliferation activities against tumor cells. HDAC-IN-32 shows potent antitumor efficacy in vivo That trigger antitumor immunity[1].
Product Specifications
CAS Number
2766688-17-7
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hdac-in-32.html
Solubility
10 mM in DMSO
Smiles
O=C(NO)CCCCCCOC1=CC=CC(C2=NC3=CC=CC=C3N2)=C1
Molecular Formula
C20H23N3O3
Molecular Weight
353.41
References & Citations
[1]"Chen C, et al. Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antitumor Immunity. J Med Chem. 2022 Feb 24;65 (4) :3667-3683. "
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740304-500 1x 500 µL
CD106 / VCAM1 (B-K9), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941063-100 1x 100 µL
VEGF-A (VEGF/1063), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682590-500 1x 500 µL
CD10 (Membrane Metalloendopeptidase) (MME/2590), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
1310000-65-35.500MG 500 mg
Ɑ-Butyric Acid NHS Ester-ω-Maleimidohexanamido PEG
Sign In for Pricing
View Details